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Abstract 1 
Objective 2 
To describe the use of pericardial catheters in dogs with pericardial effusion (PE), 3 
and detail any associated adverse events. 4 
Design 5 
Retrospective study. 6 
Setting 7 
University teaching hospital. 8 
Animals 9 
Eighteen client-owned dogs that had pericardial catheters placed for pericardial 10 
fluid drainage between May 2007 and January 2015. 11 
Interventions 12 
None. 13 
Measurements and main results 14 
All pericardial catheters were placed within 5 hours of presentation, usually 15 
within 1 hour (median 72.5 minutes, range 45-300 minutes, mode 60 minutes). 16 
Ten of 18 cases were sedated with butorphanol, and 4 with additional midazolam. 17 
Four had pericardial catheters positioned for single drainage only and were 18 
immediately removed. The other 14 pericardial catheters remained in situ for a 19 
median of 18 hours (range 2-88 hours). Ten of the remaining 14 cases were re-20 
drained after pericardial catheter placement. The main adverse events reported 21 
were new arrhythmias in 6/18 cases, with 4 of these 6 patients being 22 
administered anti-arrhythmic therapy. No infectious or functional complications 23 
were reported. Ten patients were discharged, 1 died and 7 were euthanised.  24 
Conclusions 25 
2 
Thoracic drainage catheters inserted into the pericardial space via a modified-26 
Seldinger technique can be positioned in dogs to aid management of pericardial 27 
effusions. The main associated adverse event is arrhythmia. Minimal sedation is 28 
required for placement, and dogs tend not to require post procedural analgesia. 29 
Catheters can remain in situ for repeated drainage, potentially decreasing staffing 30 
time requirement and repeat sedation. Their use is associated with a rate of 31 
arrhythmia requiring treatment of 22%, compared to that of needle 32 
pericardiocentesis alone at 13%. They are easy to position using equipment 33 
available in many facilities. 34 
  35 
3 
Abbreviations 36 
PE, Pericardial effusion. 37 
 38 
Keywords 39 
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 41 
Introduction 42 
In dogs, the pericardial space usually contains approximately 0.25ml/kg 43 
bodyweight of clear, serious fluid as lubrication between the visceral and 44 
parietal pericardium; an excess or inappropriate fluid presence is termed a 45 
pericardial effusion (PE).1,2 The etiology of canine pericardial effusion is most 46 
frequently neoplastic or idiopathic, with less common causes including 47 
coagulopathy, left atrial rupture, local septic effusions and congestive heart 48 
failure.1,3-5 49 
In the emergent situation, pericardial effusion can lead to cardiovascular 50 
instability involving cardiac tamponade, reduced preload and compromised 51 
cardiac output. This may necessitate drainage of fluid from the pericardial space. 52 
Needle pericardiocentesis is well described as a simple and efficacious technique 53 
for treating cardiac tamponade.1 However, pericardial effusion can recur and 54 
cause clinical signs, requiring repeated drainage.  Repeated pericardiocentesis 55 
has been reported to be necessary in 25-31% of cases of canine pericardial 56 
effusion, although the timescale to re-effusion is highy variable.4,6 Should it occur 57 
during the same hospital visit this may increase animal stress and staffing 58 
requirements, and may necessitate further sedation in a cardiovascularly 59 
unstable patient. 60 
4 
Pericardial catheter placement and ‘extended pericardial catheter 61 
drainage’ is well documented in human medicine, being the standard of care for 62 
management and repeated drainage of pericardial effusions, and has been shown 63 
to prevent further fluid accumulation in both malignant and idiopathic 64 
effusions.7,8 Extended pericardial catheter drainage refers to the process of 65 
continued, elective drainage of pericardial effusion by indwelling catheter every 66 
4-6 hours until the effusion is minimal in volume (25-30ml/day). This is usually 67 
for approximately 4 days. In human pericardial catheter placement, the incidences 68 
of major complications, such as myocardial or coronary artery laceration, and 69 
severe arrhythmias (usually vasovagal bradycardia) are both less than 2%.7 70 
Although over the needle central venous catheters have been recommended for 71 
single drainage previously,9 there have been no studies reporting or investigating 72 
extended pericardial catheter drainage in veterinary medicine. The equipment 73 
required for pericardial catheter placement and extended drainage is readily 74 
available but there is no evidence indicating a clear advantage or disadvantage of 75 
its use or information regarding its safety. 76 
This retrospective study serves to describe the use of pericardial 77 
catheters in dogs with pericardial effusion, including reported adverse events to 78 
aid assessment of whether they are beneficial in case management. 79 
  80 
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Materials and methods 81 
Medical records at a veterinary teaching hospital were searched for cases 82 
of canine pericardial effusion which were managed with a pericardial catheter 83 
between May 2007 and January 2015. Animals with incomplete records were 84 
excluded from the study. Information collected included signalment, weight, 85 
whether needle pericardiocentesis had been performed prior to pericardial 86 
catheter placement, time from presentation to pericardial catheter placement, 87 
sedatives or local anesthetic drugs used to aid catheter placement, adverse 88 
events reported, presence of arrhythmias, whether arrhythmias were treated, 89 
details of repeated drainages, length of drain persistence, analgesics used post 90 
placement, final diagnosis and outcome.  91 
 92 
Statistical methods 93 
All continuous data was assessed for normality using a Shapiro-Wilk Test 94 
and descriptive data calculated as appropriate using commercially available 95 
software.a 96 
 97 
Results 98 
Ethical approval was granted by the Clinical Research Ethical Review 99 
Board (CRERB) (reference number M2016 0087). Twenty-five cases of canine 100 
pericardial effusion in which pericardial catheters were placed were identified. 101 
Seven cases were excluded due to incomplete records leaving 18 cases in the 102 
study. In the same period there were 94 additional cases of pericardial effusion 103 
managed by needle pericardiocentesis alone. The breeds represented were 104 
Labrador Retrievers (4), German shepherds (3), Golden Retrievers (3), 105 
6 
Greyhounds (2) Bull Mastiffs (2) and one each of the following breeds: Pyrenean 106 
Mountain Dog, Bull Terrier, Rottweiler, Crossbreed.  The mean (± SD) age of 107 
dogs involved in this study was 96 (± 30) months. Eleven males (7 neutered) 108 
and 7 females (6 neutered) were included. The mean weight  (± SD) of the dogs 109 
was 41.8kg (± 9.3) kg with the smallest weighing 26.7kg 110 
Twelve dogs had a presumed neoplastic cause of PE based on 111 
echocardiography by a board certified cardiologist (mass lesion identified), 4 112 
had a presumed idiopathic cause (no mass lesion identified) and 2 did not 113 
undergo complete investigations prior to death or euthanasia and a cause was 114 
not determined. The majority of presumed neoplastic sites were right atrial or 115 
auricular in origin and there were no examples of iatrogenic or post-surgical 116 
effusions requiring drainage. 117 
All catheters were 20cm chest tubesb placed percutaneously by a 118 
modified-Seldinger technique as follows: 1) Aseptic preparation of skin between 119 
ribs 4 and 6 over right hemithorax. 2) Peripheral cannula insertion (usually with 120 
a small skin incision made with a surgical blade and often ultrasound guided or 121 
planned) into the pericardial sac followed by removal of cannula stylet. 3) Guide 122 
wire insertion via peripheral cannula access. 4) Cannula removal and catheter 123 
positioning over guidewire. 5) Guide wire removal and securement of catheter to 124 
overlying skin with sutures. (Fig 1.)  Catheters were covered with a sterile 125 
adhesive dressing and often secured with elastic tubular netting.c (Fig 1.) 126 
Tunneling of the catheter subcutaneously may not be necessary, but a slight 127 
cranially directed insertion can maintain the tube flush with the skin surface. 128 
Three dogs had needle pericardiocentesis prior to re-effusion and 129 
subsequent pericardial catheter placement within 24 hours. The other 15 130 
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catheters were used for first time drainage. All pericardial catheters were placed 131 
within 5 hours of presentation with a median time to placement of 72.5 minutes 132 
(Range 30-300).  133 
Ten of the 18 dogs were sedated for pericardial catheter placement with 134 
butorphanold (median 0.2, range 0.1-0.5mg/kg) which was combined with 135 
midazolame (0.2mg/kg) in 4 cases. Four dogs received lidocainef local anesthesia 136 
in the cutaneous and muscle layers where the drain was to be placed, two 137 
without concurrent systemic sedation. Six cases had neither sedation nor local 138 
anesthesia documented, and no patients were fully anaesthetized. 139 
Two animals (11%) were described as having ongoing bleeding into the 140 
pericardial space. Of these, one had been bleeding within the pericardium prior 141 
to or after an initial needle pericardiocentesis, having a catheter placed after a 142 
second pericardiocentesis and died hours later, with coagulopathy excluded as 143 
the cause of the PE. The other had a right atrial mass identified as the cause of 144 
the PE and was euthanized electively after 3 further large volume drainages 145 
(237ml, 265ml and 346ml within 5.5 hours) due to tamponade after the initial 146 
drainage by catheter. 147 
A total of 10 dogs had arrhythmias documented during their 148 
hospitalization. As is standard procedure in this hospital, animals were 149 
monitored by continuous electrocardiogram (ECG) during and immediately post 150 
procedure, and occasionally pre-procedurally. Post-procedural ECGs were 151 
performed based on stability. In 4 cases arrhythmias were documented pre-152 
procedurally (ventricular arrhythmias, two episodes of ventricular tachycardia 153 
and one of electrical alternans). Six of 18 cases (33%) had new arrhythmic 154 
events reported at the time of pericardial catheter placement and subsequently. 155 
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These were nearly exclusively ventricular arrhythmias. Ventricular premature 156 
complexes and accelerated idioventricular rhythms predominated, with 157 
ventricular tachycardia reported in 3 of these dogs and second degree 158 
atrioventricular block in one dog. Two of the 4 dogs with ventricular 159 
arrhythmias documented pre-procedurally required lidocaine bolus treatment 160 
(2mg/kg) prior to the procedure, followed by continuous rate infusions (50-161 
80mcg/kg/min). Four of the 6 dogs with new arrhythmic events were treated 162 
with lidocaine boluses, with 2 requiring adjunctive continuous rate infusions. 163 
Two dogs with arrhythmias noted pre-catheter placement and 2 dogs with 164 
arrhythmias noted during or after placement were not treated with anti-165 
arrhythmic therapy. 166 
Six cases received post procedural analgesia (butorphanol 0.1 mg/kg or 167 
methadoneg 0.1mg/kg) which was presumed to have been administered for 168 
perceived or anticipated discomfort due to the pericardial catheter. 169 
Overall, 40 pericardial drainage events were performed using the 170 
pericardial catheters. Four dogs had pericardial catheters positioned for 171 
immediate drainage only which were subsequently removed (in one of these no 172 
fluid was retrieved, but it relieved the effusion and was immediately removed). 173 
The other pericardial catheters remained in situ for a median of 18 hours (Range 174 
2-88). Ten of the 14 dogs with catheters kept in situ after first drainage had 175 
repeat pericardial effusion drainage via the catheter, 7 of these due to a 176 
perceived clinical deterioration such as tachycardia or worsening arrhythmias, 177 
and 3 electively on a routine basis. Among the 7 cases re-drained out of apparent 178 
necessity, there were 12 re-drainage events. 179 
9 
Pericardial catheters were placed and removed at the clinician’s 180 
discretion, but appeared to be removed due to euthanasia or stability being 181 
achieved and animals being discharged. No infectious or functional adverse 182 
events were reported. 183 
Ten of the 18 cases survived to discharge, 7 were euthanized and 1 died 184 
during hospitalization. The patient that died was hemorrhaging catastrophically 185 
prior to drain placement, having had two needle pericardiocentesis events 186 
already at the QMHA. 187 
 188 
Discussion 189 
This retrospective study describes the use of pericardial catheters in dogs 190 
with pericardial effusion, demonstrating an alternative to needle 191 
pericardiocentesis in this disease process, either in the first instance or in cases 192 
requiring repeated drainage. Caution should clearly be exercised before 193 
considering this procedure in the first instance without more rigorous 194 
demonstration of safety or benefit, however. The population described in this 195 
study is consistent with previous retrospective studies of canine pericardial 196 
effusion, with Golden Retrievers, German Shepherd Dogs and males apparently 197 
over-represented.4 There were high numbers of presumed neoplastic aetiologies 198 
(66% of the population), with 31-68% reported previously.4,10 199 
The pericardial catheters in this study were positioned easily, under 200 
minimal sedation and with occasional local anesthesia only. Six patients received 201 
no procedural sedation nor local anesthesia. This is presumed to be a function of 202 
both the retrospective nature of this study, and occasional moribund patients 203 
that may well have been drained without these drugs. There was one report of a 204 
10 
lack of retrieval of pericardial fluid after placement of the catheter, however, the 205 
effusion was relieved in this case. All other catheters were placed on the first 206 
attempt and pericardial fluid was obtained. In some cases, it appeared that 207 
pericardial catheters were placed as repeated pericardiocentesis was required (3 208 
cases); however, in other cases it was unclear why this choice was made over 209 
standard needle pericardiocentesis and it is likely there was a degree of clinician 210 
preference. Procedural length was rarely documented nor collated but in the 211 
authors’ experience it takes approximately 20 minutes from skin preparation to 212 
dressing the catheter, including drainage. Previous reported use of the same 213 
equipment for management of pleural space disease documented placement 214 
times of less than 10 minutes in the vast majority of cases.11 215 
No adverse events that could be definitively directly attributable to 216 
pericardial catheter placement were noted. One of the catheters failed to recover 217 
any volume of effusion and so was removed immediately but it was noted that 218 
the effusion had resolved, presumably due to pericardial penetration.  219 
New ventricular arrhythmias were identified in 6 of 18 dogs (33%) at the 220 
time of pericardial drain placement, 4 requiring treatment (22%). It is not 221 
possible to state whether these arrhythmias were related to pericardial catheter 222 
placement specifically, were manifestations of the underlying disease or were 223 
secondary to pericardial stimulation which would have occurred with any fluid 224 
drainage technique.  Arrhythmias are commonly reported in dogs with 225 
pericardial effusion4,6 and in this study 4 of the dogs had ventricular arrhythmias 226 
reported prior to catheter placement, one of which had a needle 227 
pericardiocentesis performed previously. It is possible that arrhythmias were 228 
present prior to catheter placement but not recognized until an ECG was 229 
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performed during the procedure and monitored post-procedurally as is standard 230 
practice at our hospital. It could be that the cases selected for catheter placement 231 
were considered less stable resulting in closer monitoring and more consistent 232 
documentation of adverse events in a slightly more complex procedure than 233 
needle pericardiocentesis. It is also possible that the catheters themselves 234 
initiated or perpetuated the arrhythmias. In human pericardial catheter 235 
placement, the major complications are laceration and perforation of the 236 
myocardium and coronary vessels, with the frequency of these complications 237 
reduced by echocardiographic guidance, and even more by fluoroscopic 238 
guidance.7 239 
A retrospective study of dogs undergoing needle pericardiocentesis 240 
reported a 13% rate of arrhythmias requiring treatment,6 which is not markedly 241 
different to the rate of arrhythmias requiring treatment (22%) in this study. 242 
Given the low frequency (4/18) of treatment of new ventricular arrhythmias in 243 
dogs with pericardial catheters positioned, it may be concluded that they were 244 
often of limited clinical significance as they did not require more than lidocaine 245 
bolus (4 cases) or continuous rate infusions (2 of these 4 cases). Future attempts 246 
ought to be made to ascertain whether such arrhythmias are catheter derived 247 
and hence avoidable. No dog underwent cardiopulmonary arrest secondary to 248 
the arrhythmias noted. If treatment of these is rarely required, it might seem 249 
reasonable to tolerate their presence so long as perfusion is not compromised, 250 
and to be vigilant of their potential progression as with any ventricular 251 
arrhythmia. 252 
Two dogs (11%) were described as having ongoing bleeding. Both were 253 
considered cardiovascularly unstable on presentation and one had a right atrial 254 
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mass identified as the cause of the effusion. This dog had a pericardial catheter 255 
positioned in the first instance and it is impossible to conclude whether the 256 
catheter placement or right atrial mass was responsible for ongoing bleeding. 257 
The other died without a diagnosis being achieved, but the catheter was 258 
positioned due to immediate re-effusion post needle pericardiocentesis and 259 
hence the continued bleeding was either a function of the underlying disease or a 260 
previous pericardiocentesis. A coagulopathy was excluded. It is impossible to 261 
exclude pericardial catheter placement as a cause of ongoing bleeding in this 262 
case, but there was no suggestion of concerns for this in the clinical notes.  Other 263 
explanations would include relieving the pericardial pressure and potentiating 264 
ongoing bleeding from an undiagnosed tumor. Adverse events other than 265 
arrhythmias described in a retrospective study of needle pericardiocentesis 266 
included ongoing bleeding in 3 of 85 cases (all of which had neoplasia as a cause 267 
of PE) and cardiopulmonary arrest in 4 of 85 cases.6 268 
In the setting that repeat pericardiocentesis may be required with 269 
urgency, if there are no significant contraindications to maintaining a pericardial 270 
catheter in place, such as local pyoderma, then having one present carries 271 
obvious advantages. In people, extended pericardial catheter drainage is 272 
associated with a reduction in the recurrence of idiopathic and postoperative 273 
effusions by 44-77%.12,13 They are associated with a lack of malignant pericardial 274 
effusion recurrence also.14 The mechanism of this is postulated to be in 275 
fenestration of the pericardium by persistence of the catheter. In one study of 276 
pericardiocentesis in dogs, 29% of patients required repeated pericardiocentesis 277 
and based on the human literature, preventing recurrence of pericardial 278 
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effusions is a potentially unrecognized benefit of extended pericardial catheter 279 
drainage in veterinary medicine.6 280 
In this study the length of time the pericardial catheter remained in situ 281 
appeared to be at the clinician’s discretion.  Four catheters were placed solely for 282 
immediate pericardiocentesis prior to removal, suggesting they were placed as 283 
the clinician preferred this technique to standard pericardiocentesis.  No 284 
catheters were removed due to documented complications. Specific reasons for 285 
removal were not possible to determine and this is a limitation of the study, 286 
although they appeared to serve their purpose well and be removed pending 287 
discharge from the hospital or euthanasia. In human medicine where extended 288 
pericardial catheter drainage is utilized, they are drained every 4-6 hours or as 289 
necessary until fluid accumulation is less than 25-30 ml/day.15 290 
Many of the indications for pericardiocentesis in human medicine arise 291 
after cardiothoracic surgery, or ventricle perforation during catheter assisted 292 
procedures such as pacemaker placement, valvuloplasty or pulmonary artery 293 
catheterization, with “primary” malignancy related effusions still predominating. 294 
It is possible that with increasing interventional radiology and cardiothoracic 295 
surgery procedures being performed in veterinary medicine, pericardial catheter 296 
drainage may be increasingly required post-procedurally and post-surgically. 297 
This study is limited by its retrospective nature and also by the fairly 298 
small numbers of animals described. There was also no clear reasoning 299 
described in the records why pericardial catheters were placed rather than 300 
performance of needle pericardiocentesis, with 15 of 18 being used for first time 301 
drainage.  It is therefore assumed that catheters were placed at the clinician’s 302 
14 
discretion as no protocol, outlining clear indications, currently exists for their 303 
use at this teaching hospital but this cannot be definitively stated. 304 
In conclusion, this study demonstrates that pericardial catheters can be 305 
placed to allow drainage of pericardial effusion, which can then be repeated if 306 
necessary. No adverse events were noted which could definitively be attributed 307 
to the catheter placement, but concurrent ventricular arrhythmias were seen. 308 
The advantage of placement of these catheters is that repeated drainage of 309 
effusion can be performed by a suitably qualified person (veterinarian or 310 
technician) alone, and that this can be performed without the stress and 311 
potential complications of repeated needle pericardiocentesis. It also introduces 312 
the concept of extended pericardial catheter drainage which may offer further 313 
advantages. Although not evaluated in this study, it is possible that procedural 314 
time is slightly longer than needle pericardiocentesis and likely that cost would 315 
be higher. Efficacy and safety of pericardial catheter use and extended 316 
pericardial catheter drainage would best be assessed with a prospective study. 317 
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Footnotes 319 
a IBM SPSS Statistics, Version 22, New York, USA 320 
b 14ga x 20cm (8in) Catheter fenestrated up to 8cm mark, MILA International Inc. 321 
Medical Instrumentation for Animals, Kentucky, USA 322 
c Colorline Surgifix, elastic tubular netting, FRA production, Dusino San Michele, 323 
Italy 324 
d Alvegesic vet. 10mg/ml, Dechra, Shrewsbury, UK 325 
e Hypnovel 10mg/2ml, Roche Products Limited, Welwyn, UK 326 
f  2% Lidocaine, Braun Melsungen, Melsungen, Germany 327 
g Comfortan 10mg/ml, Dechra, Shrewsbury, UK 328 
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Figure Legends 373 
Figure 1. Pericardial catheter placement. 374 
A MILA® chest tube was used in all cases. An aseptic technique is used 375 
throughout. 376 
A. Kit includes large bore peripheral IV cannula for access, guide wire, chest tube, 377 
clamps and bungs. 378 
B. IV cannula secures access into the pericardial space. 379 
C. Guide wire is passed into the pericardial space through the cannula. 380 
D. Tube is threaded into position by Seldinger technique and secured to skin 381 
surface. 382 
 383 
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